HIV vaccine research in Canada.
作者信息
Shattock Robin
机构信息
Department of Medicine, Imperial College London, Norfolk Place, London, W2 1PG, UK.
出版信息
AIDS Res Ther. 2017 Sep 12;14(1):54. doi: 10.1186/s12981-017-0181-8.
Abstract
摘要
相似文献
1
HIV vaccine research in Canada.加拿大的艾滋病疫苗研究。
AIDS Res Ther. 2017 Sep 12;14(1):54. doi: 10.1186/s12981-017-0181-8.
2
HIV-1/AIDS vaccine development: are we in the darkness.人类免疫缺陷病毒1型/艾滋病疫苗研发：我们仍在黑暗中吗？
Chin Med J (Engl). 2008 May 20;121(10):939-45.
3
New research in HIV immunity points way for vaccine.关于艾滋病病毒免疫的新研究为疫苗指明了方向。
Expert Rev Clin Immunol. 2013 May;9(5):403.
4
5
Vaccine reactions.疫苗反应
Nat Med. 1998 Jul;4(7):746. doi: 10.1038/nm0798-746a.
6
Hope for HIV control in southern Africa: The continued quest for a vaccine.南部非洲控制艾滋病的希望：对疫苗的持续探索。
PLoS Med. 2017 Feb 28;14(2):e1002241. doi: 10.1371/journal.pmed.1002241. eCollection 2017 Feb.
7
[Development of a vaccine against HIV: is this aim accomplishable?].[开发抗HIV疫苗：这一目标可实现吗？]
MMW Fortschr Med. 2013 Jun 13;155 Suppl 1:36-9.
8
AIDS vaccine 'within 5 years'.艾滋病疫苗将在5年内问世。
Expert Rev Vaccines. 2002 Aug;1(2):125. doi: 10.1586/14760584.1.2.125.
9
[Prospects for vaccine development against HIV infection].[针对HIV感染的疫苗研发前景]
Verh Dtsch Ges Inn Med. 1991;97:394-402.
10
HIV vaccine development--improving on natural immunity.HIV疫苗研发——改进天然免疫
N Engl J Med. 2011 Sep 8;365(10):873-5. doi: 10.1056/NEJMp1107621.
本文引用的文献
1
Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention.在不针对病毒的情况下预防艾滋病毒感染：减少生殖道艾滋病毒靶细胞如何成为预防艾滋病毒的新方法。
AIDS Res Ther. 2017 Sep 12;14(1):46. doi: 10.1186/s12981-017-0166-7.
2
HIV-I Nef inhibitors: a novel class of HIV-specific immune adjuvants in support of a cure.HIV-1 Nef抑制剂：一类新型的HIV特异性免疫佐剂，助力治愈目标。
AIDS Res Ther. 2017 Sep 12;14(1):53. doi: 10.1186/s12981-017-0175-6.
3
Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.HIV通过宿主载脂蛋白B mRNA编辑酶催化多肽样3G/F（APOBEC3G/F）酶的作用逃避适应性免疫。
AIDS Res Ther. 2017 Sep 12;14(1):44. doi: 10.1186/s12981-017-0173-8.
4
Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design.肠道微生物群和全身炎症对HIV疫苗有效性及疫苗设计的潜在影响。
AIDS Res Ther. 2017 Sep 12;14(1):48. doi: 10.1186/s12981-017-0164-9.
5
Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions.与预防HIV感染相关的自然杀伤（NK）细胞受体-HLA配体基因型组合：保护性基因型如何影响抗HIV NK细胞功能的研究。
AIDS Res Ther. 2017 Sep 12;14(1):38. doi: 10.1186/s12981-017-0172-9.
6
The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field.包皮环切术降低HIV易感性的生物学机制：对预防领域的更广泛影响。
AIDS Res Ther. 2017 Sep 12;14(1):49. doi: 10.1186/s12981-017-0167-6.
7
Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.性激素和阴道微生物群在女性生殖道对HIV-1易感性及黏膜免疫中的作用
AIDS Res Ther. 2017 Sep 12;14(1):39. doi: 10.1186/s12981-017-0169-4.
8
Development of targeted adjuvants for HIV-1 vaccines.用于HIV-1疫苗的靶向佐剂的研发。
AIDS Res Ther. 2017 Sep 12;14(1):43. doi: 10.1186/s12981-017-0165-8.
9
RNA flow cytometric FISH for investigations into HIV immunology, vaccination and cure strategies.用于HIV免疫学、疫苗接种及治愈策略研究的RNA流式细胞术荧光原位杂交技术
AIDS Res Ther. 2017 Sep 12;14(1):40. doi: 10.1186/s12981-017-0171-x.
10
Eradication of HIV-1 latent reservoirs through therapeutic vaccination.通过治疗性疫苗接种根除HIV-1潜伏库。
AIDS Res Ther. 2017 Sep 12;14(1):45. doi: 10.1186/s12981-017-0177-4.
Zotero 插件